A Simple Intervention to Increase Persistence on PrEP in MSM to Improve Decision Making
The Role of Cognitive Biases in the Decision to Request, Offer, Accept and Continue on PrEP From a Health Care Provider and Patient Perspective (Men Who Have Sex With Men)
2 other identifiers
interventional
106
2 countries
2
Brief Summary
Oral HIV pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention modality that requires individuals to take a daily tablet to prevent themselves acquiring HIV. In South Africa while this is freely available in the public sector, persistence (that is continuation after initiation) is low amongst vulnerable populations, including men who have sex with men (MSM). This study is a feasibility and acceptability study of a behavioral economics informed intervention to improve persistence amongst MSM newly initiating PrEP in South Africa. The goal of this study is to show that this approach is possible in a routine setting and gather the necessary data for a fully powered effectiveness trial. Study participants will complete a baseline questionnaire and then be randomized to either receive standard of care (control) or to receive the intervention. The intervention package consists of evidence informed reminders, commitment pledges and planning prompts. The intervention package aims to address present bias, optimism bias and salience. The intervention is delivered and the enrollment visit and then through mobile phone reminders / text messages. There is no further in person interaction after the initial interaction. Participants may be contacted for a telephonic enplane questionnaire. Outcome data is obtained from passive followup through routine medical record review with the primary end point being persistence at 3 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hiv-infections
Started Jan 2025
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 21, 2024
CompletedFirst Posted
Study publicly available on registry
June 26, 2024
CompletedStudy Start
First participant enrolled
January 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
October 23, 2025
October 1, 2025
1.6 years
June 21, 2024
October 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Target population recruitment (feasibility)
The percent of participants enrolled from those that meet eligibility criteria and are offered will be assessed from screening log.
18 months
Fidelity to intervention (feasibility)
Percent of intervention interactions that are delivered in the first 3 months (Max interactions in 3 months = 2 visit reminders and 24 text messages (2 per week) = 26 total interactions).
18 months
Acceptability by intervention participants
The percent of participants that accept to participate in the intervention (set reminders/receive text messages) after being randomized to the intervention arm.
18 months
Secondary Outcomes (1)
PrEP persistence at 3 months, 6 months, and 12 months
4 months, 7 months, 13 months
Study Arms (2)
Intervention group
EXPERIMENTALParticipants randomized into this group will receive a behavioral economics informed intervention to improve persistence among amongst high risk men newly initiating PrEP in South Africa.
Control group
NO INTERVENTIONUsual care for high risk men newly initiating PrEP in South Africa.
Interventions
A light touch, once off, low cost. lay counsellor led intervention, designed to focus decision making around HIV prevention addressing present bias, salience and over optimism. The intervention package consists of evidence informed reminders, commitment pledges and planning prompts.
Eligibility Criteria
You may qualify if:
- Not currently on pre exposure prophylaxis (PrEP); no PrEP within the last 12 months
- Initiating PrEP on the date of enrolment
- Access to a mobile phone
- Willing and able to provide written informed consent in English
You may not qualify if:
- PrEP status unknown
- Previous PrEP experience within the last year (12 months from enrolment)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston Universitylead
- National Institute of Mental Health (NIMH)collaborator
Study Sites (2)
Boston Univeristy School ofPublic Health, Global Health
Boston, Massachusetts, 02118, United States
The Aurum POP INN Clinic
Pretoria, Gauteng, South Africa
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lawrence C Long, PhD MCom
Boston University School of Public Health,Global Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 21, 2024
First Posted
June 26, 2024
Study Start
January 23, 2025
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
October 23, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share